Table 1.
Summary of clinical data from patients included in all groups
| OP | UI | CC-treated | rFSH-treated | |
|---|---|---|---|---|
| No. of patients (n) | 12 | 10 | 12 | 10 |
| Age (years) | 30.83 ± 3.27 | 31.32 ± 3.58 | 31 ± 4.39 | 30.46 ± 3.95 |
| Body mass index (kg/m2) | 26.24 ± 2.70 | 26.48 ± 2.91 | 26.74 ± 2.80 | 25.98 ± 2.70 |
| Basal hormonal profile | ||||
| PRL (ng/mL) | 17.46 ± 2.44 | 13.78 ± 2.32 | 15.93 ± 2.82 | 12.75 ± 3.11 |
| E2 (pg/mL) | 35.13 ± 1.85 | 27.34 ± 3.12 | 46.61 ± 2.67 | 24.8 ± 2.28 |
| LH (IU/L) | 6.42 ± 1.16 | 4.98 ± 0.84 | 4.82 ± 1.07 | 5.80 ± 0.77 |
| FSH (IU/L) | 7.27 ± 0.94 | 8.86 ± 1.16 | 5.79 ± 0.79 | 6.07 ± 0.64 |
| LH + 7 day hormonal profile | ||||
| E2 (pg/mL) | 26 ± 2.04 | 31.05 ± 3.08 | 25.33 ± 2.16 | 48.51 ± 3.27 |
| P4 (ng/mL) | 12.01 ± 1.54 | 7.19 ± 1.98 | 20.87 ± 4.32 | 6.97 ± 1.14 |
| Histological dating (cycle day) | 19 ± 0.42 | 19 ± 0.7 | 19 ± 0.44 | 17 ± 0.79 |
Clinical data from the ovulatory patients (OP), untreated infertile (UI), clomiphene citrate (CC) and recombinant follicle stimulating hormone (rFSH) treated patients. Data represents mean ± SE. Hormonal measurement at basal condition (day 3) and after treatments in LH + 7 day, as well as histological dating in all groups